Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9599 posts found.

Novartis announces positive results from phase 3 trial of Kisqali for early breast cancer

March 27, 2023 Research and Development

Novartis has announced positive results from its phase 3 NATALEE trial assessing Kisqali (ribociclib) along with endocrine therapy (ET) in …
News

Biogen shares FDA decisions on ALS drug

March 23, 2023 Research and Development

US-based Biogen has announced two decisions the FDA’s Peripheral and Central Nervous System Drugs Advisory Committee made surrounding its ALS …
News

Kite’s Yescarta CAR T-cell therapy shows statistically significant improvement in overall survival

March 22, 2023 Research and Development

Kite has announced the primary overall survival (OS) analysis results of a phase 3 study into Yescarta for the treatment …
News

Faron Pharmaceuticals announces positive FDA feedback for solid tumour therapy

March 22, 2023 Research and Development

Faron Pharmaceuticals, a clinical stage biopharmaceutical company, has revealed positive FDA feedback and recommendations for its monotherapy for solid tumour …
News

First candidate from Nurix-Gilead Sciences collaboration exclusively licensed

March 21, 2023 Research and Development

US-based Gilead Sciences and Nurix have announced that Gilead has exercised its option to exclusively license Nurix’s investigational targeted protein …
News

AbbVie shares results from study for new psoriasis therapy

March 20, 2023 Research and Development

AbbVie has announced new 52-week data from a study assessing the efficacy of new IL-23 inhibitor, Skyrizi (risankizumab). Patients with …
News

QurAlis Corporation announces programme which targets UNC13A mis-splicing in neurodegenerative diseases

March 20, 2023 Research and Development

US-based clinical-stage biotechnology QurAlis Corporation has announced the launch of its newest programme to treat neurodegenerative diseases like ALS and …
News

Seamless Therapeutics launches with $12.5m in financing

March 16, 2023 Research and Development

Seamless Therapeutics, a biotech focusing on the therapeutic potential of gene therapies, has announced it received $12.5m (€11.8m) in seed …
News

GSK shares positive results from meningococcal disease vaccine trial

March 14, 2023 Research and Development

GSK has announced positive results from its vaccine candidate trial for meningococcal, which is a significant cause of meningitis and …
News

Occlutech launches FROST-HF study of heart failure device

March 14, 2023 Research and Development

Occlutech has announced that it has recruited its first patient in the FROST-HF study, which aims to investigate the company’s …
News

Acadia Pharmaceuticals awaits FDA decision for first-of-its-kind Rett syndrome drug

March 10, 2023 Research and Development

Acadia Pharmaceuticals is aiming to follow in the footsteps of Reata Pharmaceuticals, who won approval for its novel drug to …
News

Eli Lilly & Co’s Alzheimer’s disease drug fails to stop disease decline

March 9, 2023 Research and Development

Eli Lilly & Co have today announced that its Alzheimer’s disease (AD) hopeful did not slow the progression of cognitive …
News

AstraZeneca shares positive results from Imfinzi trial

March 9, 2023 Research and Development

Pharma giant AstraZeneca has shared positive results from a phase 3 trial on Imfinzi, its resectable non-small cell lung cancer …
News

New clinical trial aims to find new endometriosis treatment

March 8, 2023 Research and Development

A new clinical trial is set to begin shortly which will be a collaboration between the universities of Edinburgh, Aberdeen …
News

Wearable sensor helps detect heart attacks

March 7, 2023 Research and Development

RCE Technologies has developed a bracelet-like device that can measure levels of troponin-I in the patient’s blood, providing a more …
News
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026